|
|
||||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORIGINAL ARTICLE |
1 Department of Pathology, Coombe Womens Hospital, Dublin 8, Ireland
2 Department of Obstetrics and Gynaecology, Coombe Womens Hospital
3 Department of Histopathology, Trinity College Dublin, Dublin 2, Ireland
Correspondence to:
Professor J J OLeary
Department of Pathology, Coombe Womens Hospital, Dublin 8, Ireland; olearyjj{at}tcd.ie
Aim: To analyse and compare expression patterns of three potential biomarkersp16INK4A, CDC6, and MCM5and evaluate their use as predictive biomarkers in squamous and glandular cervical preinvasive neoplasia.
Methods: Immunocytochemical analysis of p16INK4A, MCM5, and CDC6 expression was performed on 20 normal, 38 cervical intraepithelial neoplasia 1 (CIN1), 33 CIN2, 46 CIN3, 10 squamous cell carcinoma, 19 cervical glandular intraepithelial neoplasia (cGIN), and 10 adenocarcinoma samples. Staining intensity was assessed using a 03 scoring system. p16INK4A, MCM5, and CDC6 expression was also examined in ThinPrep slides exhibiting mild, moderate, and severe dyskaryosis. Human papillomavirus (HPV) was detected using a modified SYBR green assay. Fluorogenic polymerase chain reaction (PCR) and solution phase PCR were used for specific HPV typing.
Results: All three markers showed a linear correlation between expression and grade of dysplasia. p16INK4A and MCM5 protein expression was upregulated in all grades of squamous and glandular dysplasia. CDC6 protein was preferentially expressed in high grade lesions and in invasive squamous cell carcinoma.
Conclusion: p16INK4A expression was closely associated with high risk HPV infectionall grades of squamous and glandular cervical lesions were immunohistochemically positive. MCM5 staining intensity was independent of high risk HPV infection, highlighting its potential as a biomarker in both HPV dependent and independent cervical dysplasia. CDC6 may be a biomarker of high grade and invasive lesions of the cervix, with limited use in low grade dysplasia. p16INK4A was the most reliable marker of cervical dysplasia. Combinations of dysplastic biomarkers may be useful in difficult diagnostic cases.
Abbreviations: CDC6, cell division cycle protein 6; cGIN, cervical glandular intraepithelial neoplasia; CIN, cervical intraepithelial neoplasia; HPV, human papillomavirus; MCM, mini chromosome maintenance; PCR, polymerase chain reaction; Rb, retinoblastoma protein
Keywords: p16; MCM5; CDC6; marker; cervical dysplasia
This article has been cited by other articles:
![]() |
K. Cuschieri and N. Wentzensen Human Papillomavirus mRNA and p16 Detection as Biomarkers for the Improved Diagnosis of Cervical Neoplasia Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2536 - 2545. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Crowther, L Turner, D Magee, and D Gibbons Role of age stratification for colposcopy referral following initial diagnosis of mild dyskaryosis J. Clin. Pathol., May 1, 2008; 61(5): 665 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lau, T. Tsuji, L. Guo, S.-H. Lu, and W. Jiang The role of pre-replicative complex (pre-RC) components in oncogenesis FASEB J, December 1, 2007; 21(14): 3786 - 3794. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liontos, M. Koutsami, M. Sideridou, K. Evangelou, D. Kletsas, B. Levy, A. Kotsinas, O. Nahum, V. Zoumpourlis, M. Kouloukoussa, et al. Deregulated Overexpression of hCdt1 and hCdc6 Promotes Malignant Behavior Cancer Res., November 15, 2007; 67(22): 10899 - 10909. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N Kalof and K. Cooper Our approach to squamous intraepithelial lesions of the uterine cervix J. Clin. Pathol., May 1, 2007; 60(5): 449 - 455. [Full Text] [PDF] |
||||
![]() |
M. Steinau, M. S. Rajeevan, D. R. Lee, M. T. Ruffin, I. R. Horowitz, L. C. Flowers, T. Tadros, G. Birdsong, M. Husain, D. C. Kmak, et al. Evaluation of RNA Markers for Early Detection of Cervical Neoplasia in Exfoliated Cervical Cells Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 295 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jaeger, D. Koczan, H.-J. Thiesen, S. M. Ibrahim, G. Gross, R. Spang, and M. Kunz Gene Expression Signatures for Tumor Progression, Tumor Subtype, and Tumor Thickness in Laser-Microdissected Melanoma Tissues Clin. Cancer Res., February 1, 2007; 13(3): 806 - 815. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |